Insight Molecular Diagnostics Inc. Proceeds from Debt, Net of Issuance Costs
Insight Molecular Diagnostics Inc. (IMDX) reported Proceeds from Debt, Net of Issuance Costs of $1.98 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2019-04-01
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for the quarter ending 2017-12-31 was $0.00.
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for the quarter ending 2017-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for the quarter ending 2017-06-30 was $0.00.
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for the quarter ending 2017-03-31 was $1.98M.
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for fiscal 2017 was $1.98M.
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for fiscal 2016 was $0.00.
- Insight Molecular Diagnostics Inc. proceeds from debt, net of issuance costs for fiscal 2015 was $0.00.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $0.00 derived: sum of 3 quarters · filed 2019-04-01 | $1.98M 10-K · filed 2019-04-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $1.98M 10-Q · filed 2018-11-13 | $1.98M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.98M 10-Q · filed 2018-08-14 | $1.98M derived: sum of 3 quarters · filed 2018-08-14 | $1.98M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $1.98M 10-Q · filed 2018-05-15 | $1.98M derived: sum of 2 quarters · filed 2018-05-15 | $1.98M derived: sum of 3 quarters · filed 2018-05-15 | $1.98M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 derived: sum of 3 quarters · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |